Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Clin Epidemiol. 2018 Jun 30;103:10–21. doi: 10.1016/j.jclinepi.2018.06.009

Table 6.

Characterizing patient preferences for effect measures

Scenario % of Patients:
Preferring standard medication Preferring new medication Preferring neither Requesting more information
“The new medication is 3 times more likely to cause liver damage than the standard medication” 100% 0% 0% 0%
“1 out of a million people who take the standard medication get liver damage; and 3 out of a million people who take the new medication get liver damage” 57% 30% 0% 14%
“1 out of 1000 people who take the standard medication get liver damage; and 3 out of 1000 people who take the new medication get liver damage” 96% 0% 0% 4%
“1 out of 10 people who take the standard medication get liver damage; and 3 out of 10 people who take the new medication get liver damage” 82% 0% 18% 0%